VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Able to give informed consent                      │ Able to give informed consent                      │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Right-handed                                       │ Right-handed                                       │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Age between 18-50 years old                        │ Age between 18-50 years old                        │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Current PTSD diagnosis                             │ Current PTSD diagnosis                             │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ clinically significant medical or neurologic       │ clinically significant medical or neurologic       │     100 │
│ condition or neurocognitive dysfunction that would │ condition or neurocognitive dysfunction that would │         │
│ affect function and/or task performance and/or     │ affect function and/or task performance and/or     │         │
│ interfere with the study protocol                  │ interfere with the study protocol                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ any current (or within past 2 months) medical      │ any current (or within past 2 months) medical      │     100 │
│ condition requiring medication that would interact │ condition requiring medication that would interact │         │
│ with dronabinol or interfere with the study        │ with dronabinol or interfere with the study        │         │
│ protocol                                           │ protocol                                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ risk of harm to self or others that requires       │ risk of harm to self or others that requires       │     100 │
│ immediate intervention                             │ immediate intervention                             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ presence of contraindications, current or past     │ presence of contraindications, current or past     │     100 │
│ allergic or adverse reaction, or known sensitivity │ allergic or adverse reaction, or known sensitivity │         │
│ to cannabinoid-like substances                     │ to cannabinoid-like substances                     │         │
│ (dronabinol/marijuana/cannabis/THC, cannabinoid    │ (dronabinol/marijuana/cannabis/THC, cannabinoid    │         │
│ oil, sesame oil, gelatin, glycerin, and titanium   │ oil, sesame oil, gelatin, glycerin, and titanium   │         │
│ dioxide)                                           │ dioxide)                                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ lack of fluency in English                         │ lack of fluency in English                         │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ positive drug screen or alcohol breathalyzer       │ positive drug screen or alcohol breathalyzer       │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ unwilling/unable to sign informed consent document │ unwilling/unable to sign informed consent document │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ currently pregnant (positive pregnancy test),      │ currently pregnant (positive pregnancy test),      │     100 │
│ planning pregnancy, or lactating (women)           │ planning pregnancy, or lactating (women)           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ under 18 or over 50 years of age                   │ under 18 or over 50 years of age                   │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ traumatic brain injury (as defined by The American │ traumatic brain injury (as defined by The American │     100 │
│ Congress of Rehabilitation as a person who has had │ Congress of Rehabilitation as a person who has had │         │
│ a traumatically induced physiological disruption   │ a traumatically induced physiological disruption   │         │
│ of brain function (i.e., the head being struck,    │ of brain function (i.e., the head being struck,    │         │
│ the head striking an object, and/or the brain      │ the head striking an object, and/or the brain      │         │
│ undergoing an acceleration/deceleration movement   │ undergoing an acceleration/deceleration movement   │         │
│ (i.e., whiplash) without direct external trauma to │ (i.e., whiplash) without direct external trauma to │         │
│ the head), as manifested by at least one of the    │ the head), as manifested by at least one of the    │         │
│ following: any loss of consciousness; any loss of  │ following: any loss of consciousness; any loss of  │         │
│ memory for events immediately before or after the  │ memory for events immediately before or after the  │         │
│ injury; any alteration in mental status at the     │ injury; any alteration in mental status at the     │         │
│ time of the incident; or focal neurological        │ time of the incident; or focal neurological        │         │
│ deficits that may or may not be transient)         │ deficits that may or may not be transient)         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ inability to tolerate small, enclosed spaces       │ inability to tolerate small, enclosed spaces       │     100 │
│ without anxiety (e.g. claustrophobia), as          │ without anxiety (e.g. claustrophobia), as          │         │
│ determined by self-report and/or a preliminary     │ determined by self-report and/or a preliminary     │         │
│ session in a mock scanner                          │ session in a mock scanner                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ left-handed                                        │ left-handed                                        │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ presence of ferrous-containing metals within the   │ presence of ferrous-containing metals within the   │     100 │
│ body (e.g., aneurysm clips, shrapnel/retained      │ body (e.g., aneurysm clips, shrapnel/retained      │         │
│ particles)                                         │ particles)                                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ anticipation of a required drug test in the 4      │ anticipation of a required drug test in the 4      │     100 │
│ weeks following the study                          │ weeks following the study                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ current diagnosis of a mood, anxiety, or other     │ current diagnosis of a mood, anxiety, or other     │     100 │
│ disorder that is more clinically salient than PTSD │ disorder that is more clinically salient than PTSD │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ current moderate or severe alcohol/drug use        │ current moderate or severe alcohol/drug use        │     100 │
│ disorder or in the past 8 weeks                    │ disorder or in the past 8 weeks                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ current or past diagnosis of bipolar and other     │ current or past diagnosis of bipolar and other     │     100 │
│ related disorders, schizophrenia spectrum, or      │ related disorders, schizophrenia spectrum, or      │         │
│ other psychotic disorders                          │ other psychotic disorders                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ concomitant treatments with medication known to    │ concomitant treatments with medication known to    │     100 │
│ have drug interactions with dronabinol, such as,   │ have drug interactions with dronabinol, such as,   │         │
│ central nervous system depressants (barbiturates,  │ central nervous system depressants (barbiturates,  │         │
│ benzodiazepines, buspirone, lithium, etc) and      │ benzodiazepines, buspirone, lithium, etc) and      │         │
│ anticholinergic agents (atropine, scopolamine,     │ anticholinergic agents (atropine, scopolamine,     │         │
│ antihistamines, etc)                               │ antihistamines, etc)                               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Physically and neurologically healthy \[confirmed  │ Physically and neurologically healthy [confirmed   │      99 │
│ by a comprehensive medical history\]               │ by a comprehensive medical history]                │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤══════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                    │   Score │
╞═══════════════════════════════════╪══════════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years │ Able to give informed consent    │      39 │
├───────────────────────────────────┼──────────────────────────────────┼─────────┤
│ Must have maximum age of 50 Years │ under 18 or over 50 years of age │      43 │
╘═══════════════════════════════════╧══════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 99
Average Levenshtein Ratio of individual lines: 95.24
OverAll Ratio: 97.12
